TrialArteriosclerosis, thrombosis, and vascular biology2014

CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects.

Andreas Gille et al.PubMed ↗Publisher ↗

No numbers read from the abstract.